Amid the Eaton fire, Dr. Ravi Salgia and his family evacuated their home and went to City of Hope to ensure patients received care. We’re thankful for Dr. Salgia and the hundreds of COH So Cal employees for their heroic efforts during this difficult time. people.com/doctor-family-…

🔥 OUR LATEST #OriginalResearch in CancerMedicine on Small Cell Neuroendocrine Carcinoma of the Urinary Tract (SCNEC-URO)👉What drives post-surgical relapse in this aggressive disease? Omar Alhalabi, MD Matt Campbell MD, MS MD Anderson Cancer Center 🔗bit.ly/3E3R7lJ A thread🧵1/

Dr Andrea Apolo, M.D. National Cancer Institute has executed phenomenal innovative investigator-initiated clinical trials in rare GU/Bladder Cancer Variants. She takes the stage at #AUC3 to educate us all! Jonathan Rosenberg MD Sumanta K. Pal, MD, FASCO Rana McKay, MD, FASCO

Sad to be missing GU ASCO this week, but check out my abstract below:

Hannah McManus presents update on IRONMAN registry data at #GU25. Hannah Dzimitrowicz McManus Phil Kantoff Duke Cancer

Calling early-career bladder cancer researchers! Apply for the John Quale Travel Fellowship to attend BCAN's annual Think Tank Meeting. Connect with leading experts and advance your career. Applications due by 3/28! Learn more and apply here: bcan.org/bcan-research/…

Really enjoyed this conference and getting to meet so many wonderful people!

Just one taste of what a 2 year fellowship with Sumanta K. Pal, MD, FASCO and the GU team with Tanya Dorff, Alex Chehrazi-Raffle, MD and Abhishek Tripathi at City of Hope looks like! I can't express how grateful I am for this incredible experience. After 14 years of medical training, I’m so excited to finally step

A brilliant clinician, passionate researcher, and above all, a kind person. Thank YOU Andrea Apolo, M.D. for showing us the way

Join our 2025 Bladder Cancer Advocacy Network BCAN team Saturday May 3 to walk for bladder cancer awareness and to support research! #EndBladderCancer #NoOneWalksAlone #ScienceIsPower #BladderCancerResearch support.bcan.org/goto/BladderCa…

Thank you Andrea Apolo, M.D. and Caris Life Sciences for the opportunity to lead this project!

So proud to present results from our phase II combination durva+tremi+bev in refractory HCC and BTC #ASCO25 #immunoForBTC #LiverCancerScience

Opening soon at the NIH!! E-VIRTUE, A Phase 2 Trial of Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors. Andrea Apolo, M.D. National Cancer Institute Nicholas Simon Dr. Andre R. Kydd Saad Atiq doi.org/10.1080/147966…

What a terrific list of folks including so many members of the GU family - Walter Stadler City of Hope, Umang Swami Huntsman Cancer Institute, Tian Zhang, MD, MHS UTSW Simmons Cancer Center, Andrea Apolo, M.D. National Cancer Institute & so many other friends! Yelena Y. Janjigian MD Devika Das, MD, MSHQS, FASCO Erika Hamilton, MD

Enjoyed working on this with Dr. Andre R. Kydd! Thank you Oncology Brothers for the opportunity and Petros Grivas Enrique Grande for the insightful discussion!

Congratulations to an outstanding person for the award and a fantastic team on the concept! I miss you all already!

Proud to share our latest on recent advances and progress in treating Bladder Cancer with the Andrea Apolo, M.D. group! Saad Atiq Nicholas Simon Elias Chandran, MBBS NCI CCR GU Malignancies doi.org/10.1002/cncr.7…

Important to distinguish #serosal findings on #PSMA 🩻vs. #parenchymal Serosal lesions are better seen on #PSMA vs CT/MRI in #ProstateCancer but likely have an indolent course even with no 🚫therapy (even on the liver!) Melissa Abel, MD et al.Nature Reviews Urology rdcu.be/eBwPs

In PubMed: Top advances of 2024: Bladder cancer with Andrea Apolo, M.D. Saad Atiq Dr. Andre R. Kydd et. al. Click to read the article: pubmed.ncbi.nlm.nih.gov/40782344/#full…

We are pleased to welcome Saad Atiq, MD, as Assistant Professor of Medicine (Hematology and Medical Oncology). His clinical focus is on genitourinary cancers. Saad Atiq Icahn School of Medicine at Mount Sinai Mount Sinai Health System